MorphoSys AG American Depositary Shares
MOR was delisted on the 2nd of August, 2024.
0 hedge funds and large institutions have $0 invested in MorphoSys AG American Depositary Shares in 2024 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 9 closing their positions.
100% less funds holding
Funds holding: 9 → 0 (-9)
100% less capital invested
Capital invested by funds: $2.53M → $0 (-$2.53M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 9
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HWAM
Hennion & Walsh Asset Management
Parsippany,
New Jersey
|
-$2.34M |
| 2 |
RhumbLine Advisers
Boston,
Massachusetts
|
-$98.3K |
| 3 |
GI
GAMMA Investing
Foster City,
California
|
-$77.6K |
| 4 |
BTI
Blue Trust Inc
Alpharetta,
Georgia
|
-$17.6K |
| 5 |
Barclays
London,
United Kingdom
|
-$1.03K |
MOR Hedge Fund Activity: Q4 2024 in Review
0 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in MorphoSys AG American Depositary Shares (MOR) for Q4 2024, worth a combined $0 — down 100% from $2.53M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of MOR and 0 opened new positions — a net loss of 9 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Hennion & Walsh Asset Management, exiting entirely with an estimated $2.34M sold.
- 0 institutional investors held MorphoSys AG American Depositary Shares (MOR) as of Q4 2024, down from 9 in Q3 2024.
- Funds reported $0 of MorphoSys AG American Depositary Shares stock for Q4 2024, down 100% quarter-over-quarter.
- 0 funds opened new MorphoSys AG American Depositary Shares positions in Q4 2024 and 9 closed out, a net change of -9 holders.
- The largest MorphoSys AG American Depositary Shares seller in Q4 2024 was Hennion & Walsh Asset Management, an estimated $2.34M sold.
Based on aggregated 13F filings for Q4 2024.